Bristol-Myers Squibb Company
TRICYCLIC SULFONE COMPOUND AS A ROR GAMMA MODULATOR
Last updated:
Abstract:
There is described a ROR.gamma. modulator of the formula (I), ##STR00001## or stereoisomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof. Also provided are pharmaceutical compositions comprising the same. The compound of the invention may be useful in methods for modulating ROR.gamma. activity in a cell and methods for treating a subject suffering from a disease or disorder in which the subject would therapeutically benefit from modulation of ROR.gamma. activity, for example, autoimmune and/or inflammatory disorders.
Status:
Application
Type:
Utility
Filling date:
16 May 2019
Issue date:
21 Nov 2019